Immunovant CTO Jay Stout Sells 40,000 Shares at Weighted Average Prices

Jay Stout, Chief Technology Officer of Immunovant, Inc., filed a Form 4 disclosing the sale of 40,000 shares of common stock on June 26, 2026. The transactions consisted of two separate sales: 33,277 shares at a weighted average price of $38.18 per share (within a range of $37.74-$38.56) and 6,723 shares at a weighted average price of $38.94 per share (within a range of $38.76-$39.13). Following these transactions, Stout's direct holdings decreased to 211,685 shares. The sales were executed through multiple transactions at varying prices within the specified ranges, with the officer providing to disclose detailed pricing information upon request. This filing represents routine insider trading disclosure required by Section 16 of the Securities Exchange Act.